438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- - Investment decisions - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-05-29 06:55:23 Pharmacology Monoclonal antibodies Centocor Health Ustekinumab Psoriatic nails Etanercept Psoriatic arthritis Biologic Immunosuppressants Psoriasis Medicine		438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- Add to Reading List Source URL: preview.thenewsmarket.com Download Document from Source Website File Size: 212,21 KB Share Document on Facebook

	www.medscape.com/viewarticle/864011_print www.medscape.com DocID: 1pzpz - View Document
	Ixekizumab for moderate to severe chronic plaque psoriasis DocID: 1gyoS - View Document
	438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- DocID: 1fNC6 - View Document
	STELARATM (ustekinumab) STN: BLHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STELARA™ safely and effectively. See full prescribing information for STE DocID: 1ceTm - View Document
	Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement DocID: 1a6Du - View Document